ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer

Objectives: Our study was aimed to make sure whether ADAM12 could serve as a prognostic biomarker of estrogen receptor (ER) -positive breast cancer. Methods: 127 patients with ER-positive breast cancer were included in the present study. The level of ADAM12 was assayed through real-time quantitative...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Clin Exp Pathol
Asıl Yazarlar: Ma, Bo, Ma, Qianqian, Jin, Chunhui, Wang, Xiaohong, Zhang, Guolei, Zhang, Huiying, Seeger, Harald, Mueck, Alfred O
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: e-Century Publishing Corporation 2015
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4680475/
https://ncbi.nlm.nih.gov/pubmed/26722530
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller